← All companies

IVEV

Inventiva S.A.

IVEVF Nasdaq Pharmaceutical Preparations EDGAR ↗

$3.59

+0.00 0.00%

Key statistics

from XBRL data in SEC filings

Market cap

$694M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$2.28 – $5.75

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K/A FORM 6-K/A Jul 30, 2026 6-K FORM 6-K Jul 29, 2026 6-K FORM 6-K Jul 9, 2026 6-K FORM 6-K Jul 6, 2026 6-K FORM 6-K Jun 12, 2026 6-K FORM 6-K Jun 12, 2026 6-K FORM 6-K Jun 9, 2026 6-K FORM 6-K Jun 3, 2026 6-K FORM 6-K Jun 3, 2026 6-K FORM 6-K May 26, 2026 6-K FORM 6-K May 22, 2026 6-K FORM 6-K Apr 22, 2026 20-F Apr 8, 2026 6-K FORM 6-K Mar 30, 2026 6-K FORM 6-K Feb 17, 2026 6-K FORM 6-K Nov 28, 2025 6-K FORM 6-K Nov 24, 2025 6-K FORM 6-K Nov 17, 2025 6-K FORM 6-K Nov 13, 2025 6-K FORM 6-K Nov 7, 2025 6-K FORM 6-K Nov 6, 2025 6-K FORM 6-K Nov 6, 2025 6-K FORM 6-K Oct 30, 2025 6-K FORM 6-K Oct 20, 2025 6-K FORM 6-K Oct 14, 2025 6-K FORM 6-K Oct 1, 2025 6-K Sep 29, 2025 6-K FORM 6-K Jul 29, 2025 6-K FORM 6-K Jul 9, 2025 6-K FORM 6-K Jul 7, 2025 6-K FORM 6-K May 23, 2025 6-K FORM 6-K May 23, 2025 6-K FORM 6-K May 22, 2025 6-K FORM 6-K May 5, 2025 6-K FORM 6-K May 2, 2025 6-K FORM 6-K Apr 30, 2025 6-K FORM 6-K Apr 30, 2025 6-K FORM 6-K Apr 24, 2025 20-F FORM 20-F Apr 15, 2025 6-K FORM 6-K Apr 11, 2025